GGrantIndex
← Leaderboards

Kunwar Shailubhai

Callisto Pharmaceuticals, Inc.

$2,411,746
Attributed
$2,599,670
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $510.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,599,670 · 7

By mechanism

R43$960,212 · 4
U01$876,831 · 1
R21$762,627 · 2

Top collaborators

Others in their field

Top investigators on “Guanylate Cyclase

Research focus

Guanylate CyclaseColonic PolypsAnalogColitisUroguanylinColorectal CancerCyclic GmpProductionPolypsEpithelial CellsAgonistTissuesGuanylinInflammationNovel StrategiesColon CarcinomaAdenocarcinomaCell LinePharmaceutical PreparationsMucous MembraneInflammatoryOral AdministrationInflammatory Bowel DiseasesColon Carcinogenesis

Grant awards (11)